home / stock / pbm / pbm news

PBM News and Press, Psyence Biomedical Ltd. From 01/21/26

Stock Information
Company Name: Psyence Biomedical Ltd.
Stock Symbol: PBM
Market: NASDAQ
Website: www.psyencebiomed.com
Menu
PBM PBM Quote PBM Short PBM News PBM Articles PBM Message Board
Get PBM Alerts

News, Short Squeeze, Breakout and More Instantly...
PBM - US Companies Moving the Markets, Evening edition
Wed, Jan 21, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 11.5% to $1.92 on volume of 525,100,160 shares Intel Corporation (INTC) rose 11.2% to $53.995 on volume of 177,546,761 shares ProShares UltraShort Silver -2x Shares (ZSL) rose 6.6%...
PBM - Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced that it has decided to postpone the previously announced effective date of its reverse stock split of its issued and outstanding share...

PBM - Psyence Biomedical sets Jan. 20 as effective date for reverse stock split

2026-01-15 01:46:22 ET More on Psyence Biomedical Ltd. Seeking Alpha’s Quant Rating on Psyence Biomedical Ltd. Financial information for Psyence Biomedical Ltd. Read the full article on Seeking Alpha For further details see: Psyence Biomedical sets...

PBM - Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) of the Company's issued and outstanding common shares. ...
PBM - Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that its Board o...

PBM - Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a significant sc...

PBM - US Companies Moving the Markets, Morning edition
Mon, Dec 22, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Luminar Technologies Inc. (LAZR) rose 174.7% to $0.6044 on volume of 895,789,983 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 7.8% to $3.21 on volume of 332,438,875 shares NVIDIA Corporation (NVDA) rose 3.9% to $180.99...
PBM - US Companies Moving the Markets, Evening edition
Fri, Dec 19, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Luminar Technologies Inc. (LAZR) rose 134.5% to $0.516 on volume of 739,495,927 shares ProPhase Labs Inc. (PRPH) fell 12.6% to $0.0919 on volume of 344,813,162 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 8.9% to $3.17...

PBM - Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that the Bellber...

PBM - Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science

NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today released a year-end Letter...
Previous 10 Next 10